| Servicios De Hospicio De Adjuntas Calle Rodulfo Gonzalez 46 Suite 1, Adjuntas, PR, 00601 | |
| (787) 829-2953 |
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| Name | Servicios De Hospicio De Adjuntas |
|---|---|
| Location | Calle Rodulfo Gonzalez 46 Suite 1, Adjuntas, Puerto Rico |
| Hospice ID | 401549 |
| Category | Freestanding Hospice |
| Ownership Type | Proprietary - Individual |
| Profit Type | FOR PROFIT |
| SSA county code | 010 |
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| NPI Number | 1326043407 |
| Organization Name | Corporacion De Servicios De Salud De Adjuntas Inc |
| Address | 46 Calle Rodulfo Gonzalez Adjuntas, Puerto Rico, 00601 |
| Phone Number | (787)829-2953 |
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 98.8 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 97.6 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 100.0 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 100.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 100.0 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | Not Available | 93.3 |
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| Home Health Aides | 2 |
| Counselors | 1 |
| Homemakers | 5 |
| Licensed Practical or Vocational Nurses | 2 |
| Medical Social Workers | 1 |
| Physicians | 1 |
| Registered Nurses | 9 |
| Other Personnel | 8 |
| Total Employees | 29 |
|---|
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| Counselors | 1 |
| Others | 2 |
| Total Volunteers | 3 |
|---|
News Archive
Scientists at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the Institute of Biomedical Research of the Parc Científic de Barcelona (IRB-PCB) have now added key evidence to claims that some types of cancer originate with defects in stem cells.
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that the United States' National Institutes of Health (NIH) has awarded a $6.4 million grant to Professor Mark Larché of McMaster University, Canada, to study mechanisms of tolerance developed by patients treated with Circassia's Toleromune® allergy therapy.
Former Republican presidential candidate and Arkansas Gov. Mike Huckabee on Tuesday during a forum about obesity expressed disappointment that the party has not focused more on health care in the presidential election, The Hill reports.
BioMimetic Therapeutics will report today the final, one year results of its North American Pivotal Study comparing Augment Bone Graft to autograft in foot and ankle fusion surgery. The presentation of the data by Dr. Timothy Daniels, associate professor of orthopedic surgery at the University of Toronto and St. Michaels Hospital, will take place at the American Orthopaedic Foot and Ankle Society (AOFAS) summer meeting.
The number of Americans under care for depression and other mental illnesses nearly doubled between 1996 and 2006, and the overall cost of treating them jumped by nearly two-thirds, according to the latest News and Numbers from HHS' Agency for Healthcare Research and Quality.
› Verified 3 days ago
| Servicios De Hospicio De Adjuntas Location: Calle Rodulfo Gonzalez 46 Suite 1, Adjuntas, Puerto Rico, 00601 Phone: (787) 829-2953 |